Food and Drug Administration
April 2, 2004
Slides
Laboratory of Immunobiochemistry - Lab Overview, FDA (HTM) (PPT)
Laboratory of Immunobiochemistry - Research Update, FDA (HTM) (PPT)
MK-571, An Inhibitor of Multidrug Resistant Protein 1 (MRP1) Selectively Blocks T Cell Activation and May Reveal Novel Drug Targets for Immunomodulation, Dr. Ronald Rabin, MD, Laboratory of Immunobiochemistry (HTM) (PPT)
Cockroach Allergen Standardization, FDA (HTM) (PPT)
Antibody Microarrays for Allergen Standardization, FDA (HTM) (PPT)